The Research Landscape
Scientific consensus on this topic has shifted meaningfully in the past three years, driven primarily by two methodological advances: large-scale wearable data enabling continuous monitoring instead of snapshot measurements, and improved statistical methods for distinguishing within-person variation from between-person differences. Both changes have simultaneously increased confidence in some previously uncertain findings and overturned others that appeared robust in smaller studies.
The finding that has most significantly changed clinical recommendations relates to individual variation. Population averages remain useful for policy purposes, but they systematically mislead individuals whose biology falls outside the median range. The standard deviation on key physiological responses is large enough that the optimal intervention for one person may produce minimal benefit β or active harm β in another. This is not a counsel of therapeutic nihilism; it is a call for personalisation that the healthcare system is only beginning to operationalise.
The Mechanism in Detail
Understanding the underlying mechanism is useful not because it is required for practical application but because it enables intelligent adaptation when standard protocols do not produce expected results. The mechanism involves a cascade of cellular events that unfolds over weeks rather than days β a timeline that creates a mismatch between when people expect to notice change and when measurable adaptation actually occurs.
This timing mismatch is one of the most significant contributors to protocol abandonment. People stop an intervention before the adaptation window has opened, then conclude the approach does not work for them. The clinical data on minimum effective duration before physiological assessment makes sense is consistently longer than the patience of individuals self-experimenting without supervision.
Implementation Notes
The evidence suggests a graduated approach: begin with the minimum effective dose, establish consistency for six weeks before adjusting, and measure using validated metrics rather than subjective perception. Subjective perception of progress correlates poorly with objective biomarker change in the first eight weeks, then converges after the initial adaptation period. Trust the timeline, not the feeling.